Thyroid tumor study: new predictive factors
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at different types of thyroid tumors to find new factors that might help predict how the disease will progress or respond to treatment. If you have been diagnosed with a thyroid tumor, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a thyroid tumor that was confirmed by a biopsy or after surgery (this is called a histological diagnosis).
- You must be 18 years old or older.
- You must sign a consent form agreeing to take part in the study.
- You must also sign a form allowing the researchers to use your personal medical data.
- You must have had at least one follow-up visit after your first cancer consultation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study is a registry that collects information about adults with certain types of thyroid cancer. It may help researchers learn more about these cancers and how people are doing over time.
This study looks at how environmental exposures may relate to thyroid cancer. If you have a suspicious thyroid nodule and are planning surgery, your biopsy or surgical tissue may be used to understand risk factors.
This study collects information from people who have been diagnosed with thyroid cancer. It helps researchers understand thyroid cancer and may support future research or treatments.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
Hear when a new Carcinoma of Head/Neck trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.